William Foley
Analyst · Stephens. Please go ahead
Thank you, Jamie. Today, our country and world, as all of you know, are in the midst of a significant battle against COVID-19, which has impacted all of us. Our first priority, of course, is the health and safety of our employees and customers across all our portfolio companies. We are working daily with our management teams as we adapt to this new environment in order to ensure that we minimize disruption, while effectively maintaining the seamless operations of our businesses. During the course of my career, I have seen my fair share of challenging environments, which have helped shape my investment philosophy. This includes the importance of having outstanding management teams, essential businesses with strong intellectual property and trade secrets, and most importantly, a fortress-like balance sheet to weather the storm and take advantage of market dislocations. Cannae's strategy remains unchanged. We continue to monetize our investments, nurture our portfolio of companies, make new investments and prospect for future investment opportunities. Our pipeline of potential investments has expanded during the market dislocation. And Cannae has ample capital to be optimistic when the economy begins to stabilize. At Dun & Bradstreet, or D&B, we have made significant progress improving our operations in a short period of time. As previously announced, the management team completed its goal of achieving $200 million of annualized expense savings by year-end 2019, several months ahead of schedule, and have currently identified an additional $50 million in cost efficiencies that will be taken out over the course of 2020. Of note, the strength of D&B's competitive position is evident in the demand the company is experiencing as a result of the COVID-19 pandemic, particularly from the United States government. D&B's customers are more reliant than ever on D&B's data and analytics for strategic decision making, reflected in the year-over-year first quarter adjusted revenue growth of 3% to $414 million. Additionally, the D&B team delivered first quarter year-over-year adjusted EBITDA growth of 17% to $151 million and adjusted EBITDA margin expansion of 440 basis points to 36.6% over the prior quarter. During the quarter, Cannae rebalanced its portfolio by selling 3.9 million shares of Ceridian at a price of $72.75 per share. This resulted in gross proceeds of approximately $283.7 million, and we recorded a gain of $223.1 million. As of April 30, 2020, Cannae owns 19.7 million shares of Ceridian stock worth approximately $1.2 billion. Turning to AmeriLife, we closed on our previously announced commitment to invest $125 million for an approximate 20% position in the company. AmeriLife is a large US independent insurance marketing organization and has developed, marketed and distributed life and health insurance, annuities and retirement planning solutions to pre-retirees for nearly 50 years. We understand that the current environment poses challenges. And as I have commented, we have a very strong track record of acquiring significant companies in key markets during market dislocations. We have a strong network, and our pipeline remains robust. As potential deals arise, we are well positioned to deploy our capital, continuing to deliver long-term value to our shareholders. We remain very optimistic to further grow Cannae. With that, I'll turn the call over to Rick Cox to review our financial results.